Reprint
Polymers Enhancing Bioavailability in Drug Delivery
Edited by
November 2022
260 pages
- ISBN978-3-0365-5684-0 (Hardback)
- ISBN978-3-0365-5683-3 (PDF)
This book is a reprint of the Special Issue Polymers Enhancing Bioavailability in Drug Delivery that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
This Special Issue provides an update on the state of the art and current trends in polymeric drug-delivery systems specifically designed for improving drug bioavailability. The multiple contributions received further strengthen the role of polymers in modern drug delivery and targeting, illustrating the different approaches possible and unveiling what the future may bring.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
cystic fibrosis; Pseudomonas aeruginosa; liposomes; efflux pump inhibitor; PABN; aminoglycosides; macrolides; poloxamer; thiourea; thiolation; mucoadhesion; drug release; in vivo analysis; in vitro dissolution studies; S-propargyl-cysteine; poly(lactic acid); endogenous hydrogen sulfide; water-in-oil-in-water; rheumatoid arthritis; chitosan; drug delivery; drug absorption; intestinal assimilation; oral bioavailability; nanoemulsions; micelles; SEDDS; zeta potential; sustained release; albumin nanoparticle; MPT0B291; high-pressure homogenizer; histone deacetylase; calix[8]arenes; silibinin; inclusion complexes; PEGylation; cytotoxicity; oromucosal films; sodium alginate; nanoparticle drug carriers; digoxin; zein; heart failure; polymer–liposome complexes; Pluronic®-poly(acrylic acid); Pluronic®-poly(N,N-dimethylaminoethyl methacrylate); stimuli-responsive; intelligent drug delivery systems; liposome; polymer; drug delivery; long circulation; polymer–lipid conjugates; targeting; stimulus-responsive; antibody; affinity; cyclodextrin; protein therapeutics; sustained drug delivery; Nitric oxide; hydrogel; wound dressing; chronic wounds; glycyrrhetinic acid; Soluplus®; solid dispersions; anti-inflammatory; biosafety; bioavailability; n/a